Evidence & Research Status
This is an educational overview of compounds studied in tissue-repair and recovery research. Everything here describes what the published literature reports — mostly in cell and animal models — and…
Evidence Level reflects the general state of published research for this compound category and is not a claim about the safety, efficacy, or approval status of any product sold on this site. All compounds are offered strictly for research use.
By Charles Fowler, Founder of Portal to Wellness · Last reviewed: June 2026 · ~9 min read
This is an educational overview of compounds studied in tissue-repair and recovery research. Everything here describes what the published literature reports — mostly in cell and animal models — and is for research and educational purposes only. It is not medical advice, a therapeutic claim, or a dosing instruction, and nothing here describes use in humans. Our products are sold strictly for laboratory research.
“Recovery” is one of the most active corners of peptide research, and it’s easy to see why: the body’s repair machinery touches everything from connective tissue to gut lining to skin. This guide maps the compounds most studied in recovery and repair research — what each one is, what the literature explores, and how researchers think about combining them. If you want the deep dive on the two best-known players, we have a dedicated piece on how BPC-157 and TB-500 work together; this is the wider map.
Key Takeaways
- The body’s natural repair process follows a predictable biological sequence that research compounds aim to support.
- BPC-157 is studied for its proposed gut-derived, broad-spectrum repair properties.
- TB-500 is studied for its cell-migration and signaling role in tissue repair.
- GHK-Cu rounds out the trio with its copper-tripeptide-specific research angle.
How the body’s repair process actually works
Tissue repair in the research literature is usually described in overlapping phases: an inflammatory phase that clears debris and signals damage, a proliferative phase where new tissue and blood vessels form, and a remodeling phase where that new tissue is reorganized and strengthened. Most recovery-research compounds are studied for how they influence one or more of these phases — which is also why researchers are interested in combinations that act on different stages.
BPC-157 — the gut-derived repair compound
BPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a protein found in gastric juice. Research — predominantly in animal models — has explored its effects on tendon, muscle, ligament, nerve, and gastrointestinal tissue, and on angiogenesis (the formation of new blood vessels). It’s the compound most associated with the “structural resilience” side of recovery research. We cover it in depth in BPC-157: What the Preclinical Research Actually Shows. Available research-use-only as a standalone injectable, an injectable BPC-157 + TB-500 blend, or oral capsules — see BPC-157 for sale in every format.
TB-500 (Thymosin Beta-4) — cell migration and signaling
TB-500 is a synthetic fragment related to Thymosin Beta-4, an actin-sequestering peptide. In the literature it’s studied for its role in cell migration, angiogenesis, and modulation of inflammation — the kind of signaling that, in research models, helps coordinate the proliferative phase of repair. Because BPC-157 and TB-500 are studied for overlapping but distinct steps, they’re the classic research pairing. Available as TB-500 (10mg).
GHK-Cu — the copper tripeptide
GHK-Cu is a copper-binding tripeptide first isolated from human plasma in 1973 by biochemist Loren Pickart. Notably, the body’s natural GHK levels decline with age. In research models it has been studied for a striking range of effects: stimulating fibroblast activity and collagen-related gene expression, helping regulate matrix metalloproteinase (MMP) balance during remodeling, reducing pro-inflammatory signaling, and acting as an antioxidant by delivering bioavailable copper.[1] Reviews note it influences a large number of genes tied to tissue remodeling.[1] It sits at the intersection of recovery and the skin/aesthetic side of repair research. Explore the full Recovery & Repair collection.
KPV — the anti-inflammatory tripeptide
KPV is a short tripeptide derived from the C-terminus of alpha-MSH. The research interest centers on its anti-inflammatory signaling, particularly in models of gut and mucosal inflammation. It’s studied less for structural rebuilding and more for the inflammatory-phase side of the recovery picture. Available as KPV and KPV capsules.
ARA-290 — tissue-protective signaling
ARA-290 is a small peptide derived from a region of erythropoietin (EPO), engineered to engage tissue-protective pathways without EPO’s effect on red blood cell production. In research it’s studied in the context of inflammation and neuropathic models. It rounds out the recovery toolkit on the protective/signaling end. Available as ARA-290 (10mg).
Why researchers think in “stacks”
The logic behind a recovery stack is straightforward: different compounds are studied for different phases and tissues, so combining them is a way to probe complementary mechanisms rather than relying on one. A common research framing pairs a structural-repair compound (like BPC-157) with a signaling/migration compound (like TB-500), and sometimes adds an anti-inflammatory (KPV) or a remodeling-and-antioxidant compound (GHK-Cu). For researchers who want a pre-grouped set, we offer a Recovery & Repair bundle.
One caveat worth stating plainly: “studied in combination” is not the same as “proven safe or effective for any use in humans.” These are research compounds, and much of the most interesting data is preclinical.
The quality question matters most here
With recovery compounds especially, what’s in the vial determines whether any research is even valid. A mislabeled or impure peptide invalidates results before you start. If you’re new to evaluating a Certificate of Analysis, read How to Read a Peptide COA and our Lab Verification process.
📄 Free download: Recovery & Repair Compound Reference
A one-page reference to the five most-studied recovery compounds (BPC-157, TB-500, GHK-Cu, KPV, ARA-290) — what each is and what the research explores. Enter your email and we’ll send it straight to your inbox — no spam, unsubscribe anytime.
Frequently asked questions
What is a recovery peptide stack?
A research term for combining compounds studied for different phases of tissue repair — e.g. a structural-repair compound with a cell-signaling one — to investigate complementary mechanisms. It is not a treatment protocol.
What’s the difference between BPC-157 and TB-500?
In the literature, BPC-157 is studied more for structural tissue (tendon, gut, ligament) and TB-500 for cell migration and signaling. They’re often researched together because they target different steps of repair.
What is GHK-Cu studied for?
Research models explore the copper tripeptide for collagen-related gene expression, tissue remodeling (MMP balance), anti-inflammatory and antioxidant activity. Its natural levels decline with age.
Are these compounds approved for human use?
No. They are sold for laboratory and research use only — not for human or veterinary use. Much of the supporting data is from cell and animal studies.
Related reading
Go deeper: BPC-157 and TB-500: Two Mechanisms Compared · BPC-157 Deep Dive · How to Read a Peptide COA
About the author
Charles Fowler is the founder and researcher behind Portal to Wellness. After a career in management consulting, he spent the past two years immersed in the wellness and research-compound space — sourcing products, vetting suppliers, and reading the primary literature daily. He isn’t a physician or a scientist, and he’ll tell you so. His goal is to translate what the research actually says into plain English so customers can make informed decisions.
How we research our content
Our Research Library articles are written from peer-reviewed scientific literature and reputable references, and we date every article. We don’t make therapeutic, dosing, or “cure” claims, and we flag where the science is preclinical or unsettled.
References
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide. International Journal of Molecular Sciences. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793244/
- Sikiric P, et al. Stable Gastric Pentadecapeptide BPC 157 and tissue healing. (Review of preclinical literature.) https://pubmed.ncbi.nlm.nih.gov/30915550/
- Goldstein AL, et al. Thymosin beta-4: actin-sequestering protein moonlights to repair injured tissues. https://pubmed.ncbi.nlm.nih.gov/16002257/
All products sold on this website are intended for research and identification purposes only. They are not intended for human dosing, injection, ingestion, or veterinary use. Must be 18 or older to purchase. This content is educational and is not medical advice.
📚 Part of our Recovery & Repair research guide.
Recovery & Repair Stack — Research Use Only